SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001297184-23-000019
Filing Date
2023-03-01
Accepted
2023-03-01 16:11:36
Documents
114
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amph-20221231x10k.htm   iXBRL 10-K 4164547
2 EX-21.1 amph-20221231xex21d1.htm EX-21.1 14936
3 EX-23.1 amph-20221231xex23d1.htm EX-23.1 14697
4 EX-31.1 amph-20221231xex31d1.htm EX-31.1 19561
5 EX-31.2 amph-20221231xex31d2.htm EX-31.2 19094
6 EX-32.1 amph-20221231xex32d1.htm EX-32.1 9168
7 EX-32.2 amph-20221231xex32d2.htm EX-32.2 9342
8 GRAPHIC amph-20221231x10k001.jpg GRAPHIC 48673
  Complete submission text file 0001297184-23-000019.txt   16022906

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20221231.xsd EX-101.SCH 83098
10 EX-101.CAL amph-20221231_cal.xml EX-101.CAL 107159
11 EX-101.DEF amph-20221231_def.xml EX-101.DEF 362670
12 EX-101.LAB amph-20221231_lab.xml EX-101.LAB 684061
13 EX-101.PRE amph-20221231_pre.xml EX-101.PRE 643224
108 EXTRACTED XBRL INSTANCE DOCUMENT amph-20221231x10k_htm.xml XML 3223937
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36509 | Film No.: 23693597
SIC: 2834 Pharmaceutical Preparations